Pandemic Defense Platform Designed for Surge-Scaling Rapid Antigen Testing at the Point of Contact
The key to getting people back to a full, healthy life is the ability to scale access to accurate, rapid, and affordable testing
By transforming the COVID-19 rapid antigen testing arena at the point of collection, we're creating a pandemic defense and economic recovery platform with the needs of business in mind. High efficiency. Thousands of tests an hour. Individual results in 5 minutes.
The Critical Role of Antigen Testing
The Food and Drug Administration (FDA) has acknowledged the vital role of antigen tests in the overall response to COVID-19, correctly characterizing them as rapid, point-of-care tests with high scalability.
- The FDA has authorized 12 COVID-19 antigen tests under Emergency Use Authorization’s; all are low throughput.
- In September 2020, FluroTest confirmed the successful function of its novel, proprietary, and highly sensitive real-time, point-of-care antigen test, which uses fluorescence spectroscopy to quantify the SARS-CoV-2 viral load in salivary samples.